RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Icagen, Inc. (NASDAQ: ICGN) today announced that data related to two of its preclinical programs were recently presented at the Neuroscience 2006 Meeting sponsored by the Society for Neuroscience ("SFN") in Atlanta, Georgia.
